Psychometric validation of the Female Sexual Distress Scale-Desire/Arousal/Orgasm.

ABSTRACT:

Background

For the treatment of female sexual dysfunction, the most relevant outcome measures are patient-reported treatment effects and changes in symptoms, underscoring the need for reliable, validated patient-reported outcome (PRO) instruments. The aim of this study was to evaluate the psychometric characteristics (validity and reliability) of the Female Sexual Distress Scale-Desire/Arousal/Orgasm (FSDS-DAO) PRO measure, which was adapted from the validated FSDS-Revised (FSDS-R) questionnaire and added 2 questions involving arousal and orgasm.

Methods

Psychometric analyses were based on the data from a multicenter phase 2b dose-finding study that compared the safety and efficacy of bremelanotide versus placebo and were conducted in the evaluable modified intent-to-treat p

SUBMITTER: Derogatis LR 

PROVIDER: S-EPMC8463644 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature